Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy

被引:0
|
作者
Walton, Sara [1 ,2 ]
Fenyi, Alexis [3 ,4 ]
Tittle, Tyler [5 ]
Sidransky, Ellen [6 ,7 ]
Pal, Gian [8 ]
Choi, Solji [5 ]
Melki, Ronald [3 ,4 ]
Killinger, Bryan A. [5 ]
Kordower, Jeffrey H. [1 ,2 ,7 ]
机构
[1] Arizona State Univ, ASU Banner Neurodegenerat Dis Res Ctr, Tempe, AZ USA
[2] Arizona State Univ, Sch Life Sci, Tempe, AZ USA
[3] CEA, Inst Francois Jacob MIRCen, Fontenay Aux Roses, France
[4] CNRS, Lab Neurodegenerat Dis, Fontenay Aux Roses, France
[5] Rush Univ, Med Ctr, Grad Coll, Chicago, IL 60612 USA
[6] Natl Human Genome Res Inst, NIH, Med Genet Branch, Bethesda, MD USA
[7] Aligning Sci Parkinsons ASAP, Collaborat Res Network, Chevy Chase, MD USA
[8] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Div Movement Disorders, New Brunswick, NJ USA
基金
美国国家卫生研究院;
关键词
PARKINSONS-DISEASE; GLUCOCEREBROSIDASE MUTATIONS; GAUCHER-DISEASE; OLFACTORY-BULB; GENE; VULNERABILITY; VARIANTS; COMPLEX; NCKAP1;
D O I
10.1038/s41531-024-00679-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive motor symptoms and alpha-synuclein (alpha syn) aggregation in the nervous system. For unclear reasons, PD patients with certain GBA1 mutations (GBA-PD) have a more aggressive clinical progression. Two testable hypotheses that can potentially account for this phenomenon are that GBA1 mutations promote alpha syn spread or drive the generation of highly pathogenic alpha syn polymorphs (i.e., strains). We tested these hypotheses by treating homozygous GBA1 D409V knockin (KI) mice with human alpha-syn-preformed fibrils (PFFs) and treating wild-type mice (WT) with several alpha syn-PFF polymorphs amplified from brain autopsy samples collected from patients with idiopathic PD and GBA-PD patients with either homozygous or heterozygous GBA1 mutations. Robust phosphorylated-alpha syn (PSER129) positive pathology was observed at the injection site (i.e., the olfactory bulb granule cell layer) and throughout the brain six months following PFF injection. The PFF seeding efficiency and degree of spread were similar regardless of the mouse genotype or PFF polymorphs. We found that PFFs amplified from the human brain, regardless of patient genotype, were generally more effective seeders than wholly synthetic PFFs (i.e., non-amplified); however, PFF concentration differed between these two studies, which might also account for the observed differences. To investigate whether the molecular composition of pathology differed between different seeding conditions, we performed Biotinylation by Antibody Recognition on PSER129 (BAR-PSER129). We found that for BAR-PSER129, the endogenous PSER129 pool dominated identified interactions, and thus, very few potential interactions were explicitly identified for seeded pathology. However, we found Dynactin Subunit 2 (Dctn2) interaction was shared across all PFF conditions, and NCK Associated Protein 1 (Nckap1) and Adaptor Related Protein Complex 3 Subunit Beta 2 (Ap3b2) were unique to PFFs amplified from GBA-PD brains of heterozygous mutation carriers. In conclusion, both the genotype and alpha syn strain had little effect on overall seeding efficacy and global PSER129-interactions.
引用
收藏
页数:12
相关论文
共 1 条
  • [1] Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
    Luk, Kelvin C.
    Covell, Dustin J.
    Kehm, Victoria M.
    Zhang, Bin
    Song, Insung Y.
    Byrne, Matthew D.
    Pitkin, Rose M.
    Decker, Samantha C.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    CELL REPORTS, 2016, 16 (12): : 3373 - 3387